Low accuracy of routine ultrasound-guided systematic 12-core biopsies in prostate tumor mapping

Canadian Journal of Urology

Volumn 19, Issue 4, 2012, Pages 6366-6372

  Belas, Olivier ^a   Hupertan, Vincent ^a   Comperat, Eva ^a,b   Renard Penna, Raphaële ^a,b   Mozer, Pierre ^a,b   Bitker, Marc Olivier ^a,b   Rouprêt, Morgan ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Diagnosis of transrectal ultrasound; Gleason score; Prostate biopsy; Prostate specific antigen; Prostatic neoplasms; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; CANCER GRADING; ENDOSCOPIC ECHOGRAPHY; HUMAN; LARGE CORE NEEDLE BIOPSY; MALE; METHODOLOGY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PREDICTIVE VALUE; PROSTATE; PROSTATE TUMOR; PROSTATECTOMY;

AGED; AREA UNDER CURVE; BIOPSY, LARGE-CORE NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; ORGAN SIZE; PREDICTIVE VALUE OF TESTS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84874411013     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Siegel R, Naishadham D, Jemal A. Cancer Statistics, 2012. CA Cancer J Clin 2012;62(1):10-29.
2. Heidenreich A, Bellmunt J, Bolla M et al. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59(1):61-71.
3. Roupret M, Hupertan V, Yates DR et al. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage. Clin Cancer Res 2007;13(6):1720-1725.
4. Andriole GL, Crawford ED, Grubb RL 3rd et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 2009;360(17):1310-1319.
5. Ploussard G, Haese A, Van Poppel H et al. The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies. BJU Int 2010;106(8):1143-1147.
6. Schroder FH, Carter HB, Wolters T et al. Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics. Eur Urol 2008;53(3):468-477.
7. Ploussard G, Salomon L, Xylinas E et al. Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria. J Urol 2010;183(2):539-544.
8. Draisma G, Boer R, Otto SJ et al. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003;95(12):868-878.
9. Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM. Complications after prostate biopsy: data from SEER-Medicare. J Urol 2011;186(5):1830-1834.
10. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142(1):71-75.
11. Salomon L, Colombel M, Patard JJ et al. Value of ultrasoundguided systematic sextant biopsies in prostate tumor mapping. Eur Urol 1999;35(4):289-293.
12. Anastasiadis AG, Lichy MP, Nagele U et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 2006;50(4):738-749.
13. Mozer PC, Partin AW, Stoianovici D. Robotic image-guided needle interventions of the prostate. Rev Urol 2009;11(1):7-15.
14. Ploussard G, Bastien L, Descazeaud A et al. Extended biopsy protocol decreases prostate cancer incidence and risk of aggressive disease on repeated biopsies compared with initial standard procedure. Urol Int 2010;84(2):147-152.
15. Bruyere F, Sotto A, Escaravage L et al. Recommendations of the Infectious Disease Committee of the French Association of Urology (AFU): antibiotic prophylaxis for urological procedures. Prog Urol 2010;20(2):101-108.
16. Falzarano SM, Zhou M, Hernandez AV et al. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. Urology 2010;76(3):682-687.
17. Sinnott M, Falzarano SM, Hernandez AV et al. Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: Implications for focal therapy. Prostate 2011;DOI: 10.1002/pros.22467
18. Lim CH, Quinlan DM. Are doctors examining prostates in university hospital. Urology 2007;70(5):843-845.
19. Philip J, Dutta Roy S, Ballal M, Foster CS, Javle P. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer. BJU Int 2005;95(7):969-971.
20. Futterer JJ. MR imaging in local staging of prostate cancer. Eur J Radiol 2007;63(3):328-334.
21. Katahira K, Takahara T, Kwee TC et al. Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 2011;21(1):188-196.
22. Hambrock T, Somford DM, Hoeks C et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 2010; 183(2):520-527.
23. Mitterberger M, Pinggera GM, Horninger W et al. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol 2007;178(2):464-468.
24. Nelson ED, SlotoroffCB, Gomella LG, Halpern EJ. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology 2007;70(6):1136-1140.
25. Bill-Axelson A, Holmberg L, Ruutu M et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352(19):1977-1984.
26. Chun FK, Briganti A, Graefen M et al. Development and external validation of an extended 10-core biopsy nomogram. Eur Urol 2007;52(2):436-444.
27. Karakiewicz PI, Benayoun S, Kattan MW et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 2005;173(6):1930-1934.
28. Roupret M, Hupertan V, Comperat E et al. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy. BJU Int 2009;104(6):813-818.
29. Ukimura O, Hung AJ, Gill IS. Innovations in prostate biopsy strategies for active surveillance and focal therapy. Curr Opin Urol 2011;21(2):115-120.
30. de la Taille A, Antiphon P, Salomon L et al. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate. Urology 2003;61(6):1181-1186.
31. Jones JS, Patel A, Schoenfield L et al. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006;175(2):485-488.
32. Badani KK, Kaul S, Menon M. Evolution of robotic radical prostatectomy: assessment after 2766 procedures. Cancer 2007; 110(9):1951-1958.
33. Drouin SJ, Vaessen C, Hupertan V et al. Comparison of midterm carcinologic control obtained after open, laparoscopic, and robot-assisted radical prostatectomy for localized prostate cancer. World J Urol 2009;27(5):599-605.
34. Shikanov SA, Zorn KC, Zagaja GP, Shalhav AL. Trifecta outcomes after robotic-assisted laparoscopic prostatectomy. Urology 2009;74(3):619-623.
35. Hull GW, Rabbani F, Abbas F et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002; 167(2 Pt 1):528-534.
36. Boccon-Gibod LM, Dumonceau O, Toublanc M, Ravery V, Boccon-Gibod LA. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Eur Urol 2005; 48(6):895-899.
37. Katz B, Srougi M, Dall'oglio M et al. Are we able to correctly identify prostate cancer patients who could be adequately treated by focal therapy. Urol Oncol 2011;doi:10.1016/j.urolonc. 2010.11.008.
38. Xylinas E, Ploussard G, Salomon L et al. Intrafascial nervesparing radical prostatectomy with a laparoscopic robot-assisted extraperitoneal approach: early oncological and functional results. J Endourol 2010;24(4):577-582.
39. Abdollah F, Scattoni V, Raber M et al. The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy. BJU Int 2011;108(3):366-371.
40. Scattoni V, Raber M, Abdollah F, et al. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy. Eur Urol 2010;57(11):1-8.
41. Baumann M, Mozer P, Daanen V, Troccaz J. Prostate biopsy assistance system with gland deformation estimation for enhanced precision. Med Image Comput Comput Assist Interv 2009;12(Pt 1): 67-74.
42. Mozer P, Baumann M, Chevreau G, Troccaz J. Image fusion: use in the control of the distribution of prostatic biopsies. Prog Urol 2008;18(1 Suppl FMC):F15-8.